← Evidence map

ReviewTargeted oncology2016

Dinutuximab: A Review in High-Risk Neuroblastoma.

Sheridan M HoyPubMed ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26891967